Results 121 to 130 of about 1,856,875 (191)

Soluble urokinase plasminogen activator receptor: A new biomarker

Current Medicine Research and Practice, 2015
Gunjan Garg, Atul Gogia, Atul Kakar
openaire   +1 more source

Can serum soluble urokinase plasminogen activator receptor be an effective biomarker in comparing the inflammatory response between laparoscopic and open appendectomy?

Videosurgery and Other Miniinvasive Techniques, 2023
Basak Erginel, Meltem Karadeniz, Secil Yuksel, Hayriye Ciftci, Demet Izgi, Cenk Ersavas, Erbug Keskin, Feryal Soysal   +7 more
doaj   +1 more source

Circulating Soluble Urokinase Plasminogen Activator Receptor and C-Reactive Protein Concentrations in Adults with High-Functioning Autism. [PDF]

Brain Sci
Kurtulmuş A, Ereğli B, Nas Dönmez B, Görmez A.   +3 more
europepmc   +1 more source

Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank. [PDF]

J Am Heart Assoc
Sakr SM, Medina-Inojosa JR, Liu C, Chuckaree ID, Agusala V, Lodhi R, Mecklai Z, Owais M, Al Kasem M, Hritani W, Hasan M, Hayek S, Sun YV, Quyyumi AA.   +13 more
europepmc   +1 more source

Evaluation of Serum Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Different Metabolic Obesity Phenotypes and Their Association with Inflammatory Cytokines: A Cross-Sectional Study. [PDF]

J Clin Med
Acet A, Ozdemir C, Solak H.
europepmc   +1 more source

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

People with kidney disease are disproportionately affected by atherosclerosis for unclear reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived mediator of kidney disease, levels of which are strongly associated with ...
Pinsky, DJ, Wei, C, Melander, O, Erne, GK, Desch, KC, Tekmulla, A, Hayek, SS, Wang, H, Holton, GH, Ozel, AB, Engström, G, Ullum, H, Haas, ME, Thørner, LW, Pankow, JS, Pedersen, OB, Fahed, AC, Ismail, A, Reiser, J, Dowsett, J, Orho-Melander, M, Hindy, G, Willer, CJ, Blakely, P, Lotta, LA, Banasik, K, Heckbert, SR, Presswalla, F, Murthy, VL, Michael Amadi, K, Erikstrup, C, Brunak, S, Vasbinder, A, Zhao, L, Ostrowski, SR, Launius, C, Nielsen, JB, Eugen-Olsen, J, Tyrrell, DJ, Graham, S, Sotoodehnia, N, Goldstein, DR   +41 more
core   +1 more source

The relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission. [PDF]

Rev Assoc Med Bras (1992)
Koc BL, Tanacan A, Haliloglu E, Yilmaz HE, Ersak DT, Aktas BA, Aktas BA, Kara O, Sahin D.   +8 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease. [PDF]

Diabetes Care
Sakr SM, Desai S, Medina-Inojosa J, Liu C, Razavi AC, Yadalam AK, Ko YA, Ahmed T, Harris KA, Huang J, Yeboah R, Haroun N, Hartsfield JD, Owais M, Lodhi R, Eldaidamouni AA, Al Kasem M, Ali MK, Narayan KMV, Pasquel FJ, Tandon N, Mohan V, Quyyumi AA.   +22 more
europepmc   +1 more source

Soluble Urokinase Plasminogen Activator Receptor (suPAR): Role in the Risk Stratification of Potentially Infected Patients Presenting at the Emergency Department. [PDF]

Diagnostics (Basel)
Baldetti M, Velocci S, Belardi R, Di Lecce VN, Paganelli C, Fortunato NA, Ricciardulli T, Terrinoni A, Pieri M, Bernardini S, Legramante JM, Minieri M.   +11 more
europepmc   +1 more source

Letter to the editor: Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study. [PDF]

ESC Heart Fail
Raza A, Gulfishan S.
europepmc   +1 more source